(19)
(11) EP 0 628 079 A1

(12)

(43) Date of publication:
14.12.1994 Bulletin 1994/50

(21) Application number: 93904270.0

(22) Date of filing: 26.02.1993
(51) International Patent Classification (IPC): 
G01N 33/ 53( . )
A61K 39/ 395( . )
C07K 7/ 06( . )
C07K 16/ 00( . )
C12N 15/ 51( . )
C12P 21/ 08( . )
C12Q 1/ 70( . )
A61K 39/ 00( . )
A61K 39/ 29( . )
A61P 31/ 12( . )
C07K 14/ 18( . )
C12N 15/ 09( . )
C12P 21/ 02( . )
C12Q 1/ 68( . )
G01N 33/ 576( . )
(86) International application number:
PCT/GB1993/000410
(87) International publication number:
WO 1993/017111 (02.09.1993 Gazette 1993/21)
(84) Designated Contracting States:
AT BE CH DE ES FR GB IE IT LI NL SE

(30) Priority: 28.02.1992 GB 19920004274

(71) Applicant: THE WELLCOME FOUNDATION LIMITED
London NW1 2BP (GB)

(72) Inventor:
  • PIKE, Ian
    Bromley, Kent. BR2 9RX (GB)

(74) Representative: Marchant, James Ian, et al 
Elkington and Fife Prospect House 8 Pembroke Road
Sevenoaks, Kent TN13 1XR
Sevenoaks, Kent TN13 1XR (GB)

   


(54) HEPATITIS C VIRUS PEPTIDES